West Pharmaceutical Services Inc (NYSE:WST)
| 68.48 Real-Time Quote |  -0.26 / -0.38%Today’s Change | 44.91 Today|||52-Week Range 69.25 | +25.08% Year-to-Date |
Latest WST News | Press Releases
| What West Pharmaceutical Services's Earnings Headlines Didn't Tell You May 17 / MotleyFool.com | HSIC Misses Earnings Despite Y/Y Gain - Analyst Blog May 08 / Zacks.com |
Today’s Trading
| Previous close | 68.74 |
| Today’s open | 68.71 |
| Day’s range | 68.41 - 68.87 |
| Volume | 62,418 |
| Average volume (3 months) | 118,240 |
| Market cap | $2.4B |
| Dividend yield | 1.11% |
Data as of 2:20pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | +6.48% |
| Earnings growth (this year) | +13.77% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +6.19% |
| P/E ratio | 28.7 |
| Price/Sales | 1.47 |
| Price/Book | 3.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HAEHaemonetics Corp | +0.50 | +1.22% |
| PODDInsulet Corp | +0.05 | +0.17% |
| DXCMDexCom Inc | -0.14 | -0.66% |
| GMEDGlobus Medical Inc | -0.22 | -1.38% |
Data as of 2:20pm ET, 05/21/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.82 |
| Annual revenue (last year) | $1.3B |
| Annual profit (last year) | $80.7M |
| Net profit margin | 6.37% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Donald E. Morel, Jr., PhD |
Chief Financial Officer & Vice President William J. Federici, MBA, CPA |
Corporate headquarters Exton, Pennsylvania |
Forecasts
